Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J Angiolillo, Catherine Datto, Shane Raines, Neville D Yeomans
Journal of Thrombosis and Thrombolysis | SPRINGER | Published : 2014
These studies were sponsored and conducted by POZEN Inc. Lisa Suchower of AstraZeneca provided assistance in the statistical analysis of the data. Medical writing support was provided by Rhian Harper Owen, on behalf of Complete Medical Communications, funded by AstraZeneca.